The Beauty Health Company (NASDAQ: SKIN) reported Q2 EPS of $0.03, $0.09 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $78.2 million versus the consensus estimate of $74.51 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.